2024 CUA-KCRNC Expert Report: Management of non-clear cell renal cell carcinoma
During the 2024 Canadian Kidney Cancer Forum (CKCF) held from February 8-10, 2024, in Toronto, Ontario, Canada, a dedicated session convened an expert panel comprising urologic and medical oncologists, other healthcare professionals, and patient advocates.The purpose of this session was to facilitate a discussion on the management of nccRCC and to develop consensus statements based on the best available evidence.These statements are intended to provide practical guidance to healthcare professionals and medical practitioners in their clinical practices.Prior to the session, draft topic statements were generated by two authors (JG, PR) and subjected to review for clarity and completeness by board members of the Kidney Cancer Research Network of Canada (NB, RB, TF, ST, and LW), as detailed in Table 1.These topics spanned diagnostic imaging, pathologic classification, and genetic considerations, as well as treatment options for patients with localized and metastatic nccRCC, with a focus on papillary and chromophobe RCC.
Authors
- Dominick Bossé (ORCID: https://orcid.org/0000-0003-2992-5632)
- Susan Prendeville (ORCID: https://orcid.org/0000-0002-1068-355X)
- Ardalan E. Ahmad (ORCID: https://orcid.org/0000-0003-1469-0770)
- Jeffrey Graham (ORCID: https://orcid.org/0000-0002-8771-6815)
- Simon Tanguay (ORCID: https://orcid.org/0000-0001-6947-304X)
- Naveen S. Basappa (ORCID: https://orcid.org/0000-0002-3163-9902)
- Rodney H. Breau (ORCID: https://orcid.org/0000-0003-2344-9022)
- Aly‐Khan A. Lalani (ORCID: https://orcid.org/0000-0002-9907-9112)
- Daniel Yick Chin Heng
- Jean‐Christophe Bernhard (ORCID: https://orcid.org/0000-0001-8564-1699)
- Luke T. Lavallée (ORCID: https://orcid.org/0000-0001-9286-5965)
- Brant A. Inman (ORCID: https://orcid.org/0000-0002-6060-4485)
- Bimal Bhindi (ORCID: https://orcid.org/0000-0002-6287-9837)
- Patrick O. Richard (ORCID: https://orcid.org/0000-0002-8904-8873)
- Lori Wood (ORCID: https://orcid.org/0000-0003-2405-0216)
- Pavlos Msaouel (ORCID: https://orcid.org/0000-0001-6505-8308)
- Vincent Castonguay (ORCID: https://orcid.org/0000-0001-8053-4026)
- Christian Kollmannsberger (ORCID: https://orcid.org/0000-0002-6329-761X)
- Antonio Finelli (ORCID: https://orcid.org/0000-0003-4032-6120)
- Maryam Soleimani
- Christina M. Canil
Institutions
- Western University (CA)
- BC Cancer Agency (CA)
- Dalhousie University (CA)
- University Health Network (CA)
- The University of Texas MD Anderson Cancer Center (US)
- Université de Sherbrooke (CA)
- University of British Columbia (CA)
- University of Ottawa (CA)
- University of Alberta (CA)
- University of Calgary (CA)
- University of Toronto (CA)
- Juravinski Cancer Centre (CA)
- Ottawa Hospital (CA)
- McGill University Health Centre (CA)
- Centre Hospitalier Universitaire de Sherbrooke (CA)
- Princess Margaret Cancer Centre (CA)
- Centre Hospitalier Universitaire de Bordeaux (FR)
- Princess Margaret Hospital (NZ)
- Université Laval (CA)
- University of Manitoba (CA)
- McGill University (CA)
- McMaster University (CA)
Publication Details
- Journal
- Canadian Urological Association Journal
- Published
- 2024-10-28
- DOI
- https://doi.org/10.5489/cuaj.9041
- Citations
- 4
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.68